Article Figures & Data
Figures
- Figure 1. Flow chart of Integrated Care Boards in England and Local Health Boards in Wales and associated available prescribing formularies.
CCG = clinical commissioning group. ICB = Integrated Care Board. LHB = Local Health Board.
- Figure 2. Percentage of formularies that provided locally generated guidance only, external guidance only, both locally generated and external guidance, or no guidance; for women of reproductive age, during pregnancy and during breastfeeding (n = 73 formularies).
SSRI = selective serotonin reuptake inhibitor.
- Figure 3. Percentage of formularies that included a hyperlink to, or a description of the contents of, specific MHRA alerts regarding SSRI use (n = 73 formularies).
MHRA = Medicines and Healthcare products Regulatory Agency. PPH = postpartum haemorrhage. PPHN = persistent pulmonary hypertension in the newborn. SSRI = selective serotonin reuptake inhibitor.
Tables
Topic area Detail of data extracted ICB/LHB name The name and location of the ICB/LHB (eg, NHS Dorset ICB) Formulary location The URL of the formulary was recorded and the method by which the formulary was located (via ICB/LHB website or keyword web search) Date of extraction The date the data were extracted from the formulary Formulary version The last date the formulary was updated Formulary structure How the formulary was structured; that is, by body system (eg, central nervous system), by medication class (eg, SSRI or antidepressant), or by individual medication name (eg, sertraline) ICB = Integrated Care Board. LHB = Local Health Board. SSRI = selective serotonin reuptake inhibitor. URL = uniform resource locator.
- Table 2. Data points extracted from formularies containing locally generated guidance regarding SSRI prescribing in women of reproductive age, during pregnancy, or during breastfeeding
Data points extracted for each patient group Patient group Women of reproductive age Advice regarding first and second line SSRIs to be used in this group
Advice regarding contraindicated SSRIs in this group
Advice regarding counselling that HCPs should provide to this group regarding SSRIs
Advice regarding contraception in this group in relation to SSRIs
Advice regarding congenital abnormalities in this group in relation to SSRIs
Pregnant women Advice regarding first and second line SSRIs to be used in this group
Advice regarding contraindicated SSRIs in this group
Advice regarding counselling that HCPs should provide to this group regarding SSRIs
Breastfeeding women Advice regarding first and second line SSRIs to be used in this group
Advice regarding contraindicated SSRIs in this group
Advice regarding counselling that HCPs should provide to this group regarding SSRIs
All (women of reproductive age AND pregnant women AND breastfeeding women) Advice regarding contraception in relation to SSRIs
Advice regarding congenital abnormalities in relation to SSRIs
Advice regarding when to refer to specialist perinatal mental health
Advice regarding risk PPHN with SSRI use
Advice regarding neonatal withdrawal with SSRI use
Advice regarding PPH risk with SSRI use
HCP = healthcare professional. PPH = postpartum haemorrhage. PPHN = persistent pulmonary hypertension of the newborn. SSRI = selective serotonin reuptake inhibitor.
Supplementary Data
- EL_10.3399BJGPO.2023.0255_supp.pdf -
Supplementary material is not copyedited or typeset, and is published as supplied by the author(s). The author(s) retain(s) responsibility for its accuracy.
In this issue
Jump to section
Keywords
More in this TOC Section
Related Articles
Cited By...
